Virus-Induced Immunosuppression

Influenza Virus
  • Norbert J. RobertsJr.
  • Frank Domurat
Part of the Infectious agents and pathogenesis book series (IAPA)


Influenza virus infection is common and a significant cause of morbidity and mortality, the latter usually due to secondary (bacterial) complications.(1–3) Several recent reviews are available that discuss in depth one or more particular aspects of the anti-influenza virus immune response(4,5) including aspects of the virus that might play a role in the development of leukocyte dysfunction.(3,6) The review by Sweet and Smiths(3) is especially pertinent to any considerations of influenza virus pathogenicity. Concepts of viral immunosuppression, with attention to viruses other than influenza, are reviewed in other chapters in this volume, as well as elsewhere.(7–11)


Influenza Virus Respiratory Syncytial Virus Human Lymphocyte Influenza Virus Infection Lymphocyte Proliferative Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Davenport, F. M., Influenza viruses, in: Viral Infections of Humans: Epidemiology and Control (A. S. Evans, ed.), pp. 372–396, Plenum, New York (1982).Google Scholar
  2. 2.
    Kilbourne, E. D., Influenza as a problem in immunology, J. Immunol. 120:1447–1452 (1978).PubMedGoogle Scholar
  3. 3.
    Sweet, C., and H. Smith, Pathogenicity of influenza virus, Microbiol. Rev. 44:303–330 (1980).PubMedGoogle Scholar
  4. 4.
    Ennis, A., Some newly recognized aspects of resistance against and recovery from influenza, Arch. Virol. 73:207–217 (1982).PubMedCrossRefGoogle Scholar
  5. 5.
    Mitchell, D. M., A. J. McMichael, and J. R. Lamb, The immunology of influenza, Br. Med. Bull. 41:80–85 (1985).PubMedGoogle Scholar
  6. 6.
    Couch, R. B., The effects of influenza on host defenses, J. Infect. Dis. 144:284–291 (1981).PubMedCrossRefGoogle Scholar
  7. 7.
    Friedman, H., S. Specter, and M. Bendinelli, Influence of viruses on cells of the immune response system, in: Host Defenses to Intracellular Pathogens (T. K. Eisenstein, P. Actor, and H. Friedman, eds.), pp. 463–474, Plenum, New York (1983).CrossRefGoogle Scholar
  8. 8.
    Kirn, A., and F. Keller, How viruses may overcome non-specific defences in the host, Philos. Trans. R. Soc. Lond. B 303:115–122 (1983).CrossRefGoogle Scholar
  9. 9.
    Mims, C. A., Immunopathology in virus disease, Philos. Trans. R. Soc. Lond. B 303:189–198 (1983).CrossRefGoogle Scholar
  10. 10.
    Nash, A. A., Tolerance and suppression in virus diseases, Br. Med. Bull. 41:41–45 (1985).PubMedGoogle Scholar
  11. 11.
    Ohmann, H. B., and L. A. Babiuk, Viral infections in domestic animals as models for studies of viral immunology and pathogenesis, J. Gen. Virol. 66:1–25 (1986).CrossRefGoogle Scholar
  12. 12.
    Dolin, R., B. R. Murphy, and E. A. Caplan, Lymphocyte blastogenic responses to influenza virus antigens after influenza infection and vaccination in humans, Infect. Immun. 19:867–874 (1978).PubMedGoogle Scholar
  13. 13.
    Roberts, N. J., Jr., R. G. Douglas, Jr., R. L. Simons, and M. E. Diamond, Virus-induced interferon production by human macrophages, J. Immunol. 123:365–369 (1979).PubMedGoogle Scholar
  14. 14.
    Roberts, N. J., Jr., and R. T. Steigbigel, Effect of in vitro virus infection on response of human monocytes and lymphocytes to mitogen stimulation, J. Immunol. 121:1052–1058 (1978).PubMedGoogle Scholar
  15. 15.
    Murphy, B. R., and R. G. Webster, Influenza viruses, in: Virology (B. N. Fields, D. M. Knipe, R. M. Chanock, J. L. Melnick, B. Roizman, and R. E. Shope, eds.), pp. 1179–1239, Raven, New York (1985).Google Scholar
  16. 16.
    Palese, P., and J. F. Young, Variation of influenza A, B, and C viruses, Science 215:1468–1474 (1982).PubMedCrossRefGoogle Scholar
  17. 17.
    Webster, R. G., W. G. Laver, G. M. Air, and G. C. Schild, Molecular mechanisms of variation in influenza viruses, Nature (Lond.) 296:115–121 (1982).CrossRefGoogle Scholar
  18. 18.
    Rott, R., Molecular basis of infectivity and pathogenicity of myxovirus: Brief review, Arch. Virol. 59:285–298 (1979).PubMedCrossRefGoogle Scholar
  19. 19.
    Couch, R. B., and J. A. Kasel, Immunity to influenza in man, Annu. Rev. Microbiol. 37:529–549 (1983).PubMedCrossRefGoogle Scholar
  20. 20.
    Morris, J. A., J. A. Kasel, M. Saglam, V. Knight, and F. A. Loda, Immunity to influenza as related to antibody levels, N. Engl. J. Med. 274:527–535 (1966).PubMedCrossRefGoogle Scholar
  21. 21.
    Virelizier, J.-L., Host defenses against influenza virus: The role of anti-hemagglutinin antibody, J. Immunol. 115:434–439 (1975).PubMedGoogle Scholar
  22. 22.
    Ramphal, R., W. Fischlschweiger, J. S. Shands, and P. A. Small, Jr., Murine influenzal tracheitis: A model for the study of influenza and tracheal epithelial repair, Am. Rev. Respir. Dis. 120:1313–1324 (1979).PubMedGoogle Scholar
  23. 23.
    Murphy, B. R., D. L. Nelson, P. F. Wright, E. L. Tierney, M. A. Phelan, and R. M. Chanock, Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines, Infect. Immun. 36:1102–1108 (1982).PubMedGoogle Scholar
  24. 24.
    Virelizier, J.-L., Humoral immune response to viruses in humans, in: Human Immunity to Viruses (F. A. Ennis, ed.), pp. 71–79, Academic, New York (1983).Google Scholar
  25. 25.
    Burlington, D. B., M. L. Clements, G. Meiklejohn, M. Phelan, and B. R. Murphy, Hemagglutinin-specifìc antibody responses in immunoglobulin G, A and M isotypes as measured by enzyme-linked immunosorbent assay after primary or secondary infection of humans with influenza A virus, Infect. Immun. 41:540–545 (1983).PubMedGoogle Scholar
  26. 26.
    Wright, P. F., B. R. Murphy, M. Kervina, E. M. Lawrence, M. A. Phelan, and D. T. Karzon, Secretory immunological response after intranasal inactivated influenza A virus vaccinations: Evidence for immunoglobulin A memory, Infect. Immun. 40:1092–1095 (1983).PubMedGoogle Scholar
  27. 27.
    Waldman, R. H., P. F. Jurgensen, G. N. Olsen, R. Ganguly, and J. E. Johnson III, Immune response of the human respiratory tract. I. Immunoglobulin levels and influenza virus vaccine antibody response, J. Immunol. 111:38–41 (1973).PubMedGoogle Scholar
  28. 28.
    Scott, G. H., and R. J. Sydiskis, Responses of mice immunized with influenza virus by aerosol and parenteral routes, Infect. Immun. 13:696–703 (1976).PubMedGoogle Scholar
  29. 29.
    Mitchell, D. M., P. Fitzharris, R. A. Knight, and G. C. Schild, Kinetics of specific in vitro antibody production following influenza immunization, Clin. Exp. Immunol. 48:491–498 (1982).PubMedGoogle Scholar
  30. 30.
    Yarchoan, R., and D. L. Nelson, Specificity of in vitro anti-influenza virus antibody production by human lymphocytes: Analysis of original antigenic sin by limiting dilution cultures, J. Immunol 132:928–935 (1984).PubMedGoogle Scholar
  31. 31.
    Wylie, D. E., L. A. Sherman, and N. R. Klinman, Participation of the major histocompatibility complex in antibody recognition of viral antigens expressed on infected cells, J. Exp. Med. 155:403–414 (1982).PubMedCrossRefGoogle Scholar
  32. 32.
    Butchko, G. M., R. B. Armstrong, W. J. Martin, and F. A. Ennis, Influenza A viruses of the H2N2 subtype are lymphocyte mitogens, Nature (Lond.) 271:66–67 (1978).CrossRefGoogle Scholar
  33. 33.
    Scalzo, A. A., and E. M. Anders, Influenza viruses as lymphocyte mitogens. I. B cell mitogenesis by influenza A viruses of the H2 and H6 subtypes is controlled by the I-E/C subregion of the major histocompatibility complex, J. Immunol. 134:757–760 (1985).PubMedGoogle Scholar
  34. 34.
    Ada, G. L., and P. D. Jones, The immune response to influenza virus infection, in: Options for the Control of Influenza (A. P. Kendal and P. A. Patriarca, eds.), pp. 107–124, Liss, New York (1986).Google Scholar
  35. 35.
    Fischer, A., S. Nash, P. C. L. Beverly, and M. Feldmann, An influenza virus matrix protein-specific human T cell line with helper activity for in vitro anti-hemagglutinin antibody production, Eur. J. Immunol. 12:844–849 (1982).PubMedCrossRefGoogle Scholar
  36. 36.
    Virelizier, J.-L., P. Postlethwate, G. C. Schild, and A. C. Allison, Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory, J. Exp. Med. 140:1559–1570 (1974).PubMedCrossRefGoogle Scholar
  37. 37.
    Callard, R. E., G. W. McCaughan, J. Babbage, and R. L. Souhami, Specific in vitro antibody responses by human blood lymphocytes: Apparent nonresponsiveness of PBL is due to a lack of recirculating memory B cells, J. Immunol. 129:153–156 (1982).PubMedGoogle Scholar
  38. 38.
    Ashman, R. B., and A. Mullbacher, A T helper cell for anti-viral cytotoxic T-cell responses, J. Exp. Med. 150:1277–1282 (1979).PubMedCrossRefGoogle Scholar
  39. 39.
    Ennis, F. A., W. J. Martin, M. W. Verbonitz, and G. M. Butchko, Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: Evidence for dual recognition of H-2 and viral hemagglutinin antigens, Proc. Natl. Acad. Sci. USA 74:3006–3010 (1977).PubMedCrossRefGoogle Scholar
  40. 40.
    Leung, K. N., R. B. Ashman, H. C. J. Ertl, and G. L. Ada, Selective suppression of the cytotoxic T cell response to influenza virus in mice, Eur. J. Immunol. 10:803–810 (1980).PubMedCrossRefGoogle Scholar
  41. 41.
    Liew, F. Y., and S. M. Russell, Delayed-type hypersensitivity to influenza virus: Induction of antigen-specific suppressor T cells for delayed-type hypersensitivity to haemag-glutinin during influenza virus infection in mice, J. Exp. Med. 151:799–814 (1980).PubMedCrossRefGoogle Scholar
  42. 42.
    Reiss, C. S., and S. J. Burakoff, Specificity of the helper T cell for the cytolytic T lymphocyte response to influenza viruses, J. Exp. Med. 154:541–546 (1981).PubMedCrossRefGoogle Scholar
  43. 43.
    Biddison, W. E., and S. Shaw, Differences in HLA antigen recognition by human influenza virus-immune cytotoxic T cells, J. Immunol. 122:1705–1709 (1979).PubMedGoogle Scholar
  44. 44.
    Effros, R. B., P. C. Doherty, W. Gerhard, and J. Bennink, Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses, J. Exp. Med. 145:557–568 (1977).PubMedCrossRefGoogle Scholar
  45. 45.
    Greenspan, N. S., D. H. Schwartz, and P. C. Doherty, Role of lymphoid cells in immune surveillance against viral infection, in: Advances in Host Defense Mechanisms ,Vol. 2: Lymphoid Cells (J. I. Gallin and A. S. Fauci, eds.), pp. 101–141, Raven, New York (1983).Google Scholar
  46. 46.
    Yap, K. L., and G. L. Ada, Cytotoxic T cells in the lungs of mice infected with influenza A virus, Scand.J. Immunol. 7:73–80 (1978).PubMedCrossRefGoogle Scholar
  47. 47.
    Yap, K. L., G. L. Ada, and I. F. C. McKenzie, Transfer of specific cytotoxic T lympho cytes protects mice inoculated with influenza virus, Nature (Lond.) 273:238–239 (1978).CrossRefGoogle Scholar
  48. 48.
    Ogra, P. L., J. C. Cumella, and R. C. Welliver, Immune response to viruses, in: Immunology of the Lung and Upper Respiratory Tract (J. Bienenstock, ed.), pp. 242–263, McGraw-Hill, New York (1984).Google Scholar
  49. 49.
    Erard, F., P. Corthesy, and M. Nabholz, Induction of cytolytic T lymphocytes by lectin or alloantigen: Lack of requirement for accessory cells or differentiation factors other than interleukin-2, in: Cellular and Molecular Biology of Lymphokines (C. Sorg, A. Schimpl, and M. Landy, eds.), pp. 105–110, Academic, Orlando, Florida (1985).Google Scholar
  50. 50.
    Cambridge, G., J. S. MacKenzie, and D. Keast, Cell-mediated immune response to influenza virus infections in mice, Infect. Immun. 13:36–43 (1976).PubMedGoogle Scholar
  51. 51.
    Askonas, B. A., and P. M. Taylor, Murine cytotoxic T-cells in influenza, in: Human Immunity to Viruses (F. A. Ennis, ed.), pp. 137–149, Academic, New York (1983).Google Scholar
  52. 52.
    McMichael, A. J., F. M. Gotch, D. W. Dongworth, A. Clark, and C. W. Potter, Declining T-cell immunity to influenza, 1977–82, Lancet 2:762–764 (1983).PubMedCrossRefGoogle Scholar
  53. 53.
    Lamb, J. R., and D. D. Eckels, Human T cell recognition of influenza viral antigens and class II MHC gene products, in: Options for the Control of Influenza (A. P. Kendal and P. A. Patriarca, eds.), pp. 423–434, Liss, New York (1986).Google Scholar
  54. 54.
    Askonas, B. A., and R. G. Webster, Monoclonal antibodies to hemagglutinin and to H-2 inhibit the cross-reactive cytotoxic T cell populations induced by influenza, Eur. J. Immunol. 10:151–156 (1980).PubMedCrossRefGoogle Scholar
  55. 55.
    Hackett, C. J. ,B. A. Askonas, R. G. Webster, and K. van Wyke, Quantitation of influenza virus antigens on infected target cells and their recognition by cross-reactive cytotoxic T cells, J. Exp. Med. 151:1014–1025 (1980).PubMedCrossRefGoogle Scholar
  56. 56.
    Braciale, T. J., A. E. Lukacher, L. Morrison, V. L. Braciale, G. Smith, B. Moss, M.-J. Gething, and J. Sambrook, Influenza viral antigen recognition by class I and class II MHC restricted cytolytic T lymphocytes, in: Options for the Control of Influenza (A. P. Kendal and P. A. Patriarca, eds.), pp. 407–421, Liss, New York (1986).Google Scholar
  57. 57.
    McMichael, A. J., A. Townsend, C. A. Michie, F. M. Gotch, G. Smith, and B. Moss, Virus antigen recognition by influenza A virus specific cytotoxic T-cells, in: Options for the Control of Influenza (A. P. Kendal and P. A. Patriarca, eds.), pp. 445–451, Liss, New York (1986).Google Scholar
  58. 58.
    Askonas, B. A., and P. Pala, Cytotoxic T-cell repertoire: Individual variation in influenza A virus nucleoprotein recognition, in: Options for the Control of Influenza (A. P. Kendal and P. A. Patriarca, eds.), pp. 453–459, Liss, New York (1986).Google Scholar
  59. 59.
    Townsend, A. R. M., A. J. McMichael, N. P. Carter, J. A. Huddleston, and G. G. Brownlee, Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells, Cell 39:13–25 (1984).PubMedCrossRefGoogle Scholar
  60. 60.
    Wraith, D. C., Induction of influenza A virus crossreactive cytotoxic T lymphocytes by purified viral proteins, in: Options for the Control of Influenza (A. P. Kendal and P. A. Patriarca, eds.), pp. 461–468, Liss, New York (1986).Google Scholar
  61. 61.
    Leung, K. N., and G. L. Ada, The effect of helper T cells on the primary in vitro production of delayed-type hypersensitivity to influenza virus, J. Exp. Med. 153:1029– 1043 (1981).PubMedCrossRefGoogle Scholar
  62. 62.
    Katz, J. M., W. G. Laver, D. O. White, and E. M. Anders, Recognition of influenza virus hemagglutinin by subtype-specific and cross-reactive proliferative T cells: Contribution of HA and HA2 polypeptide chains, J. Immunol. 134:616–622 (1985).PubMedGoogle Scholar
  63. 63.
    Liew, F. Y., Delayed type hypersensitivity to influenza virus, in: Human Immunity to Viruses (F. A. Ennis, ed.), pp. 163–175, Academic, New York (1983).Google Scholar
  64. 64.
    Leung, K. N., and G. L. Ada, Cells mediating delayed-type hypersensitivity in the lungs of mice infected with an influenza A virus, Scand. J. Immunol. 12:393–400 (1980).PubMedCrossRefGoogle Scholar
  65. 65.
    Buckley, C. E., III, M. J. Zitt, and T. R. Cate, Two categories of lymphocyte unresponsiveness to phytohemagglutinin, Cell. Immunol. 6:140–148 (1973).PubMedCrossRefGoogle Scholar
  66. 66.
    Casali, P., G. P. A. Rice, and M. B. A. Oldstone, Viruses disrupt functions of human lymphocytes: Effects of measles virus and influenza virus on lymphocyte-mediated kill ing and antibody production, J. Exp. Med. 159:1322–1337 (1984).PubMedCrossRefGoogle Scholar
  67. 67.
    Jarstrand, C., and J. Wasserman, Mitogen stimulation of lymphocytes from patients with epidemic influenza, Scand. J. Infect. Dis. 8:7–11 (1976).PubMedGoogle Scholar
  68. 68.
    Kantzler, G. B., S. F. Lauteria, C. L. Cusumano, J. D. Lee, R. Ganguly, and R. H. Waldman, Immunosuppression during influenza virus infection, Infect. Immun. 10:996– 1002 (1974).PubMedGoogle Scholar
  69. 69.
    Reed, W. P., J. W. Olds, and A. L. Kisch, Decreased skin-test reactivity associated with influenza, J. Infect. Dis. 125:398–402 (1972).PubMedCrossRefGoogle Scholar
  70. 70.
    Roberts, N. J., Jr., Different effects of influenza virus, respiratory syncytial virus, and Sendai virus on human lymphocytes and macrophages, Infect. Immun. 35:1142–1146 (1982).PubMedGoogle Scholar
  71. 71.
    Roberts, N. J., Jr., M. E. Diamond, R. G. Douglas, Jr., R. L. Simons, and R. T. Steigbigel, Mitogen responses and interferon production after exposure of human macrophages to infectious and inactivated influenza viruses, J. Med. Virol. 5:17–23 (1980).PubMedCrossRefGoogle Scholar
  72. 72.
    Roberts, N. J., Jr., and J. E. Nichols, Regulation of lymphocyte proliferation after influenza virus infection of human mononuclear leukocytes, J. Med. Virol. (in press).Google Scholar
  73. 73.
    Ettensohn, D. B., and N. J. Roberts, Jr., Influenza virus infection of human alveolar and blood-derived macrophages: Differences in accessory cell function and interferon production, J. Infect. Dis. 149:942–949 (1984).PubMedCrossRefGoogle Scholar
  74. 74.
    Kleinerman, E. S., C. A. Daniels, R. P. Polisson, and R. Snyderman, Effect of virus infection on the inflammatory response: Depression of macrophage accumulation in influenza-infected mice, Am. J. Pathol. 85:373–382 (1976).PubMedGoogle Scholar
  75. 75.
    Warshauer, D., E. Goldstein, T. Akers, W. Lippert, and M. Kim, Effect of influenza viral infection on the ingestion and killing of bacteria by alveolar macrophages, Am. Rev. Respir. Dis. 115:269–277 (1977).PubMedGoogle Scholar
  76. 76.
    Jakab, G. J., G. A. Warr, and M. E. Knight, Pulmonary and systemic defenses against challenge with Staphylococcus aureus in mice with pneumonia due to influenza A virus, J. Infect. Dis. 140:105–108 (1979).PubMedCrossRefGoogle Scholar
  77. 77.
    Nugent, K. M., and E. L. Pesanti, Effect of influenza infection on the phagocytic and bactericidal activities of pulmonary macrophages, Infect. Immun. 26:651–657 (1979).PubMedGoogle Scholar
  78. 78.
    Kleinerman, E. S., R. Snyderman, and C. A. Daniels, Depressed monocyte chemotaxis during acute influenza infection, Lancet 2:1063–1066 (1975).PubMedCrossRefGoogle Scholar
  79. 79.
    Gardner, I. D., and J. W. M. Lawton, Depressed human monocyte function after influenza infection in vitro, RES: J. Reticuloendothel. Soc. 32:443–448 (1982).PubMedGoogle Scholar
  80. 80.
    Kleinerman, E. S., R. Snyderman, and C. A. Daniels, Depression of human monocyte chemotaxis by herpes simplex and influenza viruses, J. Immunol. 113:1562–1567 (1974).PubMedGoogle Scholar
  81. 81.
    Bell, D. M., N. J. Roberts, Jr., and C. B. Hall, Different antiviral spectra of human macrophage interferon activities, Nature (Lond.) 305:319–321 (1983).CrossRefGoogle Scholar
  82. 82.
    Roberts, N. J., Jr., R. G. Douglas, Jr., and R. T. Steigbigel, Interferon production by human macrophages, in: Interferon: Properties and Clinical Uses (A. Khan, N. O. Hill, and G. L. Dorn, eds.), pp. 85–93, Leland Fikes Foundation, Dallas, Texas (1980).Google Scholar
  83. 83.
    Roberts, N. J., Jr., A. H. Prill, and T. N. Mann, Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus: Respiratory syncytial virus is a potent inducer of inhibitor activity, J. Exp. Med. 163:511–519 (1986).PubMedCrossRefGoogle Scholar
  84. 84.
    Watanabe, H., and J. S. Mackenzie, Spontaneous cytotoxicity against viral-infected cells: Effects of leucocytes and sera from older mice, Cell. Immunol. 70:180–187 (1982).PubMedCrossRefGoogle Scholar
  85. 85.
    Stein-Streilein, J., M. Bennett, D. Mann, and V. Kumar, Natural killer cells in mouse lung: Surface phenotype, target preference, and response to local influenza virus infection, J. Immunol. 131:2699–2704 (1983).PubMedGoogle Scholar
  86. 86.
    Stein-Streilein, J., P. L. Witte, J. W. Streilein, and J. Guffee, Local cellular defenses in influenza-infected lungs, Cell. Immunol 95:234–246 (1985).PubMedCrossRefGoogle Scholar
  87. 87.
    Ennis, F. A., A. Meagher, A. S. Beare, Q. Yi-Hua, D. Riley, G. Schwarz, G. C. Schild, and A. H. Rook, Interferon induction and increased natural killer-cell activity in influenza infections in man, Lancet 2:891–893 (1981).PubMedCrossRefGoogle Scholar
  88. 88.
    Greenberg, S. B., H. R. Six, S. Drake, and R Couch, Cell cytotoxicity due to specific influenza antibody production in vitro after recent influenza antigen stimulation, Proc. Natl Acad. Sci. USA 76:4622–4626 (1979).PubMedCrossRefGoogle Scholar
  89. 89.
    Hashimoto, G., P. F. Wright, and D. T. Karzon, Ability of human cord blood lympho cytes to mediate antibody-dependent cellular cytotoxicity against influenza virus-infected cells, Infect. Immun. 42:214–218 (1983).PubMedGoogle Scholar
  90. 90.
    Douglas, R. G., Jr., R. H. Alford, T. R. Cate, and R. B. Couch, The leukocyte response during viral respiratory illness in man, Ann. Intern. Med. 64:521–530 (1966).PubMedGoogle Scholar
  91. 91.
    Faden, H., and P. Ogra, Neutrophils and antiviral defense, Pediatr. Infect. Dis. 5:86–92 (1986).PubMedCrossRefGoogle Scholar
  92. 92.
    Ruutu, P., A. Vaheri, and T. U. Kosunen, Depression of human neutrophil motility by influenza virus in vitro, Scand. J. Immunol 6:897–906 (1977).PubMedCrossRefGoogle Scholar
  93. 93.
    Larson, H. E., and R. Blades, Impairment of human polymorphonuclear leucocyte function by influenza virus, Lancet 1:283 (1976).PubMedCrossRefGoogle Scholar
  94. 94.
    Schlesinger, J., C. Ernst, and L. Weinstein, Inhibition of human neutrophil chemotaxis by influenza virus, Lancet 1:650–651 (1976).PubMedCrossRefGoogle Scholar
  95. 95.
    Abramson, J. S., J. C. Lewis, D. S. Lyles, K. A. Heller, E. L. Mills, and D. A. Bass, Inhibition of neutrophil lysosome-phagosome fusion associated with influenza virus infection in vitro: Role in depressed bactericidal activity, J. Clin. Invest. 69:1393–1397 (1982).PubMedCrossRefGoogle Scholar
  96. 96.
    Ruutu, P., Depression of rat neutrophil exudation and motility by influenza virus, Scand. J. Immunol 6:1113–1120 (1977).PubMedCrossRefGoogle Scholar
  97. 97.
    Abramson, J. S., D. S. Lyles, K. A. Heller, and D. A. Bass, Influenza A virus-induced polymorphonuclear leukocyte dysfunction, Infect. Immun. 37:794–799 (1982).PubMedGoogle Scholar
  98. 98.
    Busse, W. W., and J. M. Sosman, Altered luminol-dependent granulocyte chemiluminescence during an in vitro incubation with an influenza vaccine, Am. Rev. Respir. Dis. 123:654–658 (1981).PubMedGoogle Scholar
  99. 99.
    Shult, P. A., E. C. Dick, K. A. Joiner, and W. W. Busse, Role of serum in stimulation of polymorphonuclear leukocyte, luminol-dependent chemiluminescence by influenza A, Am. Rev. Respir. Dis. 131:267–272 (1985).PubMedGoogle Scholar
  100. 100.
    Mills, E. L., Y. Debets-Ossenkopp, H. A. Verbrugh, and J. Verhoef, Initiation of the respiratory burst of human neutrophils by influenza virus, Infect. Immun. 32:1200–1205 (1981).PubMedGoogle Scholar
  101. 101.
    Loosli, C. G., Influenza and the interaction of viruses and bacteria in respiratory infections, Medicine (Baltimore) 52:369–384 (1973).CrossRefGoogle Scholar
  102. 102.
    Goldman, R., and N. Hogg, Enhanced susceptibility of virus-infected fibroblasts to cytostasis mediated by peritoneal exudate cells, J. Immunol 121:1657–1663 (1978).PubMedGoogle Scholar
  103. 103.
    Jao, R. L., E. F. Wheelock, and G. G.Jackson, Production of interferon in volunteers infected with Asian influenza, J. Infect. Dis. 121:419–426 (1970).PubMedCrossRefGoogle Scholar
  104. 104.
    Chonmaitree, T., N. J. Roberts, Jr., R. G. Douglas, Jr., C. B. Hall, and R. L. Simons, Interferon production by human mononuclear leukocytes: Differences between respiratory syncytial virus and influenza viruses, Infect. Immun. 32:300–303 (1981).PubMedGoogle Scholar
  105. 105.
    Green, J. A., R. P. Charette, T-J. Yeh, and C. B. Smith, Serum interferon in humans with naturally acquired influenza, in: Current Chemotherapy and Infectious Disease ,Vol. II (J. D. Nelson and C. Grassi, eds.), pp. 1332–1334, American Society for Microbiology, Washington, D. C. (1980).Google Scholar
  106. 106.
    Hall, C. B., R. G. Douglas, Jr., R. L. Simons, and J. M. Geiman, Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections, J. Pediatr. 93:28–32 (1978).PubMedCrossRefGoogle Scholar
  107. 107.
    Mcintosh, K., Interferon in nasal secretions from infants with viral respiratory tract infections, J. Pediatr. 93:33–36 (1978).PubMedGoogle Scholar
  108. 108.
    Wyde, P. R., M. R. Wilson, and T. R. Cate, Interferon production by leukocytes infiltrating the lungs of mice during primary influenza virus infection, Infect. Immun. 38:1249–1255 (1982).PubMedGoogle Scholar
  109. 109.
    Burke, D. C., and A. Isaacs, Interferon: Relation to heterologous interference and lack of antigenicity, Acta Virol (Praha) 4:215–219 (1960).Google Scholar
  110. 110.
    Atkins, E., and W. C. Huang, Studies on the pathogenesis of fever with influenzal viruses. I. The appearance of an endogenous pyrogen in the blood following intravenous injection of virus, J. Exp. Med. 107:383–401 (1958).PubMedCrossRefGoogle Scholar
  111. 111.
    Atkins, E., and W. C. Huang, Studies on the pathogenesis of fever with influenzal viruses. II. The effects of endogenous pyrogen in normal and virus-tolerant recipients, J. Exp. Med. 107:403–414 (1958).PubMedCrossRefGoogle Scholar
  112. 112.
    Bennett, I. L., Jr., R. R. Wagner, and V. S. LeQuire, Pyrogenicity of influenza virus in rabbits, Proc. Soc. Exp. Biol. Med. 71:132–133 (1949).PubMedGoogle Scholar
  113. 113.
    Jennings, S. T., D. B. Ettensohn, and N. J. Roberts, Jr., Influenza virus infection of human alveolar and peripheral blood-derived macrophages: Production of factors that alter fibroblast proliferation, Am. Rev. Respir. Dis. 130:98–101 (1984).PubMedGoogle Scholar
  114. 114.
    Wilkinson, P. J., and R. Borland, Persistent infection of human lung cells with influenza virus, Nature (Lond.) 238:153–155 (1972).CrossRefGoogle Scholar
  115. 115.
    Ginsberg, H. S., and J. R. Blackmon, Reactions of influenza viruses with guinea pig polymorphonuclear leucocytes. I. Virus-cell interactions, Virology 2:618–636 (1956).PubMedCrossRefGoogle Scholar
  116. 116.
    Denman, A. M., B. Rager-Zisman, T. C. Merigan, and D. A. J. Tyrell, Replication or inactivation of different viruses by human lymphocyte preparations, Infect. Immun. 9:373–376 (1974).PubMedGoogle Scholar
  117. 117.
    Hackeman, M. M. A., A. M. Denman, and D. A. J. Tyrrell, Inactivation of influenza virus by human lymphocytes, Clin. Exp. Immunol. 16:583–591 (1974).Google Scholar
  118. 118.
    Roberts, N. J., Jr., and P. K. Horan, Expression of viral antigens after infection of human lymphocytes, monocytes, and macrophages with influenza virus, J. Infect. Dis. 151:308–313 (1985).PubMedCrossRefGoogle Scholar
  119. 119.
    Rodgers, B., and C. A. Mims, Interaction of influenza virus with mouse macrophages, Infect. Immun. 31:751–757 (1981).PubMedGoogle Scholar
  120. 120.
    Rodgers, B. C., and C. A. Mims, Influenza virus replication in human alveolar macrophages, J. Med. Virol. 9:177–184 (1982).PubMedCrossRefGoogle Scholar
  121. 121.
    Wells, M. A., P. Albrecht, S. Daniel, and F. A. Ennis, Host defense mechanisms against influenza virus: Interaction of influenza virus with murine macrophages in vitro, Infect. Immun. 22:758–762 (1978).PubMedGoogle Scholar
  122. 122.
    Zisman, B., and A. M. Denman, Inactivation of myxoviruses by lymphoid cells, J. Gen. Virol. 20:211–233 (1973).PubMedCrossRefGoogle Scholar
  123. 123.
    Wilson, A. B., D. N. Planterose, J. Nagington, J. R. Park, R. D. Barry, and R. R. A. Coombs, Influenza A antigens on human lymphocytes in vitro and probably in vivo, Nature (Lond.) 259:582–584 (1976).CrossRefGoogle Scholar
  124. 124.
    Butchko, G. M., R. B. Armstrong, and F. A. Ennis, Specificity studies on the proliferative response of thymus-derived lymphocytes to influenza viruses, J. Immunol. 121:2381–2385 (1978).PubMedGoogle Scholar
  125. 125.
    Mock, D. J., F. Domurat, N. J. Roberts, Jr., E. E. Walsh, M. R. Licht, and P. Keng, Macrophages are required for influenza virus infection of human lymphocytes. J. Clin. Invest. 79:620–624 (1987).PubMedCrossRefGoogle Scholar
  126. 126.
    Brownson, J. M., B. W. J. Mahy, and B. L. Hazleman, Interaction of influenza A virus with human peripheral blood lymphocytes, Infect. Immun. 25:749–756 (1979).PubMedGoogle Scholar
  127. 127.
    Merigan, T. C. Jr., and E. F. Wheelock, Virus-lymphocyte interactions, in: Progress in Immunology (B. Amos, ed.), pp. 1351–1353, Academic, New York (1971).Google Scholar
  128. 128.
    Woodruff, J. F., and J. J. Woodruff, T lymphocyte interaction with viruses and virus-infected tissues, Prog. Med. Virol. 19:120–160 (1975).PubMedGoogle Scholar
  129. 129.
    Domurat, F., D.J. Mock, N.J. Roberts, Jr., and P. C. Keng, Proliferation alone does not increase human lymphocyte susceptibility to influenza virus infection, in: Twenty-fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, Minneapolis (1985) (abst.).Google Scholar
  130. 130.
    Wyde, P. R., and T. R. Cate, Cellular changes in lungs of mice infected with influenza virus: Characterization of the cytotoxic responses, Infect. Immun. 22:423–429 (1978).PubMedGoogle Scholar
  131. 131.
    Wyde, P. R., D. L. Peavy, and T. R. Cate, Morphological and cytochemical characteriza tion of cells infiltrating mouse lungs after influenza infection, Infect. Immun. 21:140–146 (1978).PubMedGoogle Scholar
  132. 132.
    Ada, G. L., K.-N. Leung, and H. Ertl, An analysis of effector T cell generation and function in mice exposed to influenza A or Sendai viruses, Immunol. Rev. 58:5–24 (1981).PubMedCrossRefGoogle Scholar
  133. 133.
    Liew, F. Y., and S. M. Russell, Inhibition of pathogenic effect of effector T cells by specific suppressor T cells during influenza virus infection in mice, Nature (Lond.) 304:541–543 (1983).CrossRefGoogle Scholar
  134. 134.
    Hurwitz, J. L., and C. J. Hackett, Influenza-specific suppression: Contribution of major viral proteins to the generation and function of T suppressor cells, J. Immunol. 135:2134–2139 (1985).PubMedGoogle Scholar
  135. 135.
    Lipscomb, M. F., D. Yaekel-Houlihan, C. R. Lyons, R. R. Gleason, and J. Stein-Streilein, Persistence of influenza as an immunogen in pulmonary antigen-presenting cells, Infect. Immun. 42:965–972 (1983).PubMedGoogle Scholar
  136. 136.
    Jakab, G. J., C. L. Astry, and G. A. Warr, Alveolitis induced by influenza virus, Am. Rev. Respir. Dis. 128:730–739 (1983).PubMedGoogle Scholar
  137. 137.
    Owens, S. L., J. W. Osebold, and Y. C. Zee, Dynamics of B-lymphocytes in the lungs of mice exposed to aerosolized influenza virus, Infect. Immun. 33:231–238 (1981).PubMedGoogle Scholar
  138. 138.
    Zee, Y. C., J. W. Osebold, and W. M. Dotson, Antibody responses and interferon titers in the respiratory tracts of mice after aerosolized exposure to influenza virus, Infect. Immun. 25:202–207 (1979).PubMedGoogle Scholar
  139. 139.
    Astry, C. L., and G. J. Jakab, Influenza virus-induced immune complexes suppress alveolar macrophage phagocytosis, J. Virol. 50:287–292 (1984).PubMedGoogle Scholar
  140. 140.
    Lindahl-Magnusson, P., P. Leary, and I. Gresser, Interferon inhibits DNA synthesis induced in mouse lymphocyte suspensions by phytohaemagglutinin or by allogeneic cells, Nature (New Biol) 237:120–121 (1972).CrossRefGoogle Scholar
  141. 141.
    Pacheco, D., R. Falcoff, L. Catinot, F. Floc’h, G. H. Werner, and E. Falcoff, Inhibitory effect of interferon on DNA and RNA synthesis in murine spleen cells stimulated by lectins, Ann. Immunol. 127C:163–171 (1976).Google Scholar
  142. 142.
    Singer, S. H., P. Noguchi, and R. L. Kirschstein, Respiratory diseases in cyclophosphamide-treated mice. II. Decreased virulence of PR8 influenza virus, Infect. Immun. 5:957–960 (1972).PubMedGoogle Scholar
  143. 143.
    Suzuki, F., J. Ohya, and N. Ishida, Effect of antilymphocyte serum on influenza virus infection, Proc. Soc. Exp. Biol. Med. 146:78–84 (1974).PubMedGoogle Scholar
  144. 144.
    Abou-Donia, H., R. Jennings, and C. W. Potter, The spread and persistence of influenza viruses in normal and cyclophosphamide-treated mice, J. Med. Virol. 7:251–262 (1981).PubMedCrossRefGoogle Scholar
  145. 145.
    Reiss, C. S., and J. L. Schulman, Cellular immune responses of mice to influenza virus infection, Cell. Immunol. 56:502–509 (1980).PubMedCrossRefGoogle Scholar
  146. 146.
    Wells, M. A., F. A. Ennis, and P. Albrecht, Recovery from a viral respiratory infection. II. Passive transfer of immune spleen cells to mice with influenza pneumonia, J. Immunol. 126:1042–1046 (1981).PubMedGoogle Scholar
  147. 147.
    Wells, M. A., P. Albrecht, and F. A. Ennis, Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice, J. Immunol. 126:1036–1041 (1981).PubMedGoogle Scholar
  148. 148.
    Ennis, F. A., M. A. Wells, G. M. Butchko, and P. Albrecht, Evidence that cytotoxic T cells are part of the host’s response to influenza pneumonia, J. Exp. Med. 148:1241–1250 (1978).PubMedCrossRefGoogle Scholar
  149. 149.
    Yap, K. L., and G. L. Ada, The recovery of mice from influenza A virus infection: Adoptive transfer of immunity with influenza virus-specific cytotoxic T lymphocytes recognizing a common virion antigen, Scand. J. Immunol. 8:413–420 (1978).PubMedCrossRefGoogle Scholar
  150. 150.
    McLaren, C., and G. M. Butchko, Regional T-and B-cell responses in influenza-infected ferrets, Infect. Immun. 22:189–194 (1978).PubMedGoogle Scholar
  151. 151.
    Sellers, T. F., Jr., J. Schulman, C. Bouvier, R. McCune, and E. D. Kilbourne, The influence of influenza virus infection on exogenous staphylococcal and endogenous murine bacterial infection of the bronchopulmonary tissues of mice, J. Exp. Med. 114:237–255 (1961).PubMedCrossRefGoogle Scholar
  152. 152.
    Gardner, I. D., Effect of influenza virus infection on susceptibility to bacteria in mice, J. Infect. Dis. 142:704–707 (1980).PubMedCrossRefGoogle Scholar
  153. 153.
    Giebink, G. S., and P. F. Wright, Different virulence of influenza A virus strains and susceptibility to pneumococcal otitis media in chinchillas, Infect. Immun. 41:913–920 (1983).PubMedGoogle Scholar
  154. 154.
    Woodruff, J. F., and J.J. Woodruff, Lymphocyte receptors for myxoviruses and para myxoviruses, J. Immunol. 112:2176–2183 (1974).PubMedGoogle Scholar
  155. 155.
    Ennis, F. A., A. H. Rook, Q. Yi-Hua, G. C. Schild, D. Riley, R. Pratt, and C. W. Potter, HLA-restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines, Lancet 2:887–891 (1981).PubMedCrossRefGoogle Scholar
  156. 156.
    Cunningham-Rundles, S., A. Brown, D. Gross, D. Braun, J. A. Hansen, R. A. Good, D. Armstrong, and B. Dupont, Association of HLA in immune response to influenza-A immunization, Transplant. Proc. 11:1849–1852 (1979).PubMedGoogle Scholar
  157. 157.
    Spencer, M. J., J. D. Cherry, and P. I. Terasaki, HL-A antigens and antibody response after influenza A vaccination: Decreased response associated with HL-A type W16, N. Engl. J. Med. 294:13–16 (1976).PubMedCrossRefGoogle Scholar
  158. 158.
    Domurat, F., A. Nikaein, D. Mock, P. Keng, and N. J. Roberts, Jr., Demonstration and selective abrogation of class II HLA-DR-restricted activity in human mononuclear leukocytes exposed to respiratory syncytial virus, Hum. Immunol. 14:164–165 (1985).CrossRefGoogle Scholar
  159. 159.
    Lindenmann, J., E. Deuel, S. Fanconi, and O. Haller, Inborn resistance of mice to myxoviruses: Macrophages express phenotype in vitro, J. Exp. Med. 147:531–540 (1978).PubMedCrossRefGoogle Scholar
  160. 160.
    McLaren, C., and B. Pope, Macrophage dependency of in vitro B cell response to influenza virus antigens, J. Immunol. 125:2679–2684 (1980).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Norbert J. RobertsJr.
    • 1
  • Frank Domurat
    • 1
  1. 1.Infectious Diseases Unit, Department of MedicineUniversity of Rochester School of MedicineRochesterUSA

Personalised recommendations